Class IIOngoingD-0769-2021
Drug recall · September 1, 2021
Erythromycin Topical Solution USP recall
Why: Defective container: possibility for lack of seal integrity.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Erythromycin Topical Solution USP, 2%, 60mL bottle, Rx only, Teligent Pharma, Inc. Buena, NJ 08310, NDC 52565-027-59
- Lots / codes
Lot #: 14892, Exp 1/2022
- Quantity
- 7488 bottles
- Company
- Teligent Pharma, Inc., Buena, NJ
- Distribution
- USA Nationwide
- Initiated
- July 29, 2021 · Voluntary: Firm initiated
- Classified
- August 25, 2021
- Reported
- September 1, 2021
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Erythromycin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.